151 related articles for article (PubMed ID: 35060511)
1. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y; Huang Q; Li X; Zheng X; Liu M
Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
[TBL] [Abstract][Full Text] [Related]
2. The effect of surgery on primary splenic lymphoma: A study based on SEER database.
Pan X; Ren D; Li Y; Zhao J
Cancer Med; 2021 Oct; 10(20):7060-7070. PubMed ID: 34547191
[TBL] [Abstract][Full Text] [Related]
3. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
4. Survival predictors of metastatic angiosarcomas: a surveillance, epidemiology, and end results program population-based retrospective study.
Ren S; Wang Y; Wang Z; Shao J; Ye Z
BMC Cancer; 2020 Aug; 20(1):778. PubMed ID: 32811474
[TBL] [Abstract][Full Text] [Related]
5. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
Wang B; Chen LJ; Wang XY
Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics and Prognostic Factors of Primary Splenic Angiosarcoma: A Retrospective Clinical Analysis from China.
Li R; Li M; Zhang LF; Liu XM; Hu TZ; Xia XJ; Chi JS; Jiang XX; Xu CX
Cell Physiol Biochem; 2018; 49(5):1959-1969. PubMed ID: 30235449
[TBL] [Abstract][Full Text] [Related]
7. Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study.
Yu N; Zhang W; Zhong X; Song X; Li W
PLoS One; 2024; 19(3):e0300330. PubMed ID: 38466704
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis.
Li S; Wang Z; Wu Z; Zhuang H; Xu Y
Ann Hematol; 2019 Sep; 98(9):2111-2119. PubMed ID: 31227873
[TBL] [Abstract][Full Text] [Related]
9. Primary lymphoma of the female genital tract: An analysis of 697 cases.
Nasioudis D; Kampaktsis PN; Frey M; Witkin SS; Holcomb K
Gynecol Oncol; 2017 May; 145(2):305-309. PubMed ID: 28284518
[TBL] [Abstract][Full Text] [Related]
10. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
Olszewski AJ; Castillo JJ
Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
[TBL] [Abstract][Full Text] [Related]
11. Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.
Wang W; Hong J; Meng J; Wu H; Shi M; Yan S; Huang Y
Med Sci Monit; 2019 Jul; 25():5525-5535. PubMed ID: 31344019
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, tumor characteristics and survival in patients with angiosarcoma in the United States: a population-based study of 4537 cases.
Zhang C; Xu G; Liu Z; Xu Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Mao M; Wang X; Wang G; Zhang C
Jpn J Clin Oncol; 2019 Dec; 49(12):1092-1099. PubMed ID: 31612920
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
Lee KC; Chuang SK; Philipone EM; Peters SM
Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.
Fallah J; Olszewski AJ
Hematology; 2019 Dec; 24(1):378-386. PubMed ID: 30885066
[TBL] [Abstract][Full Text] [Related]
16. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of splenic tumours of lymphoid tissue.
Chen DB; Shen DH; Yang SM; Fang XZ
Pathol Res Pract; 2018 Dec; 214(12):1952-1958. PubMed ID: 30087035
[TBL] [Abstract][Full Text] [Related]
18. New nomograms to predict overall and cancer-specific survival of angiosarcoma.
Liu YY; Xu BS; Pan QZ; Weng DS; Zhang X; Peng RQ
Cancer Med; 2022 Jan; 11(1):74-85. PubMed ID: 34786885
[TBL] [Abstract][Full Text] [Related]
19. Surgery and chemotherapy improve the prognosis of primary hepatic angiosarcoma: A retrospective study based on Propensity score matched survival analysis.
Jiang S; Wu H; Lu M; Li N
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):690-698. PubMed ID: 33239254
[TBL] [Abstract][Full Text] [Related]
20. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.
Yu SC; Lin CW
Kaohsiung J Med Sci; 2013 Mar; 29(3):150-6. PubMed ID: 23465418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
